Lv4
790 积分 2023-12-21 加入
T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis
1天前
待确认
The pharmacological basis of anti-IgE therapy
7天前
已完结
Structural and Functional Insights Into IgE Receptor Interactions and Disruptive Inhibition
8天前
已完结
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy
15天前
已完结
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
18天前
已完结
Ustekinumab in active psoriatic arthritis including patients previously treated with anti–tumor necrosis factor agents: Week 24 results from PSUMMIT 2, a phase III, multicenter, double-blind, placebo-controlled study
18天前
已完结
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial
18天前
已完结
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
18天前
已完结
Efficacy of Ritlecitinib for Vitiligo Treatment Stratified by Baseline Demographic and Clinical Characteristics: Post Hoc Analysis of a Phase 2b Study
28天前
已完结
Oral ritlecitinib for the treatment of refractory vitiligo: A retrospective study
28天前
已完结
皖公网安备34019202002308
